| abstract |
A compound of formula I, or a pharmaceutically acceptable salt or solvate of said compound, is described, wherein: R is selected from the group consisting of: H, Cl, Br, F and I; T represents C or N, the dotted line linked to T representing a double bond when T represents C, absent when T represents N; and X represents O or S provided that T represents N when X represents O. A pharmaceutical composition also comprising a compound of Formula I and a pharmaceutically acceptable carrier are also described. Furthermore, the invention relates to a method of treating asthma, allergies and / or inflammations which consists in administering to a mammal in need of such treatment an effective amount of a compound of formula I. |